Depending on the viral load of the patient – how many of the antigens they have – the line will show up more boldly or faintly.

Source: https://fortune.com/well/2023/01/13/covid-tests-can-they-detect-new-variants-kraken-xbb-1-5/

For Epstein-Barr, the vaccine candidate presents antigens for the proteins gH, gL, gp42, and an antigen derived from gp350.

Source: https://medcitynews.com/2023/03/merck-vaccines-pipeline-gets-boost-via-deal-for-opko-candidate-for-epstein-barr/

Its HBV product pipeline consists of AB-729, a proprietary subcutaneously-delivered RNAi therapeutic product candidate that suppresses all HBV antigens, including HBsAg expression.

Source: https://www.etfdailynews.com/2023/07/19/arbutus-biopharma-co-nasdaqabus-sees-significant-growth-in-short-interest/

Our work to date has been on TCEs that are based on a variety of formats using OrthoMab that are pairing CD3 with tumor antigens.

Source: https://seekingalpha.com/article/4600250-abcellera-biologics-inc-abcl-q1-2023-earnings-call-transcript?source=feed_all_articles

The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a lymphocyte that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells.

Source: https://www.americanbankingnews.com/2023/06/29/brokers-set-expectations-for-nkarta-inc-s-q3-2024-earnings-nasdaqnktx.html

The startup is currently generating agents against two tumor antigens, one found on a variety of solid tumor types and another on cervical and head and neck cancers.

Source: https://www.geekwire.com/2023/seagen-vets-land-4-4m-for-univ-of-washington-spinout-using-fresh-approach-for-cancer-vaccines/